Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1993-11-22
1994-08-30
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
552653, C07C40100
Patent
active
053428331
ABSTRACT:
The invention is drawn to compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are hydrogen or acyl; provided that only one of R.sup.1 or R.sup.2 is hydrogen, useful in the treatment of hyperproliferative skin diseases and sebaceous gland diseases.
REFERENCES:
patent: 4360471 (1982-11-01), DeLuca et al.
patent: 4804502 (1989-02-01), Baggiolini et al.
patent: 5087619 (1992-02-01), Baggiolini et al.
patent: 5145846 (1992-09-01), Baggiolini et al.
patent: 5206230 (1993-04-01), Ikekawa et al.
Cancer Research vol. 50, No. 21, Nov. 1, 1990 pp. 6857-6864.
The Journal of Nutritional Biochemistry vol. 4, No. 1, Jan. 1993 pp. 49-57.
Abstract (Corresponding to WO 9214746).
Malloy, et al., The Journal of Investigative Dermatology, Mar. 1989, vol. 92, No. 3 p. 475.
Doran Thomas I.
McLane John A.
Okabe Masami
Scalone Michelangelo
Uskokovic Milan R.
Ciambrone Coletti Ellen
Gould George M.
Hoffmann-La Roche Inc.
Johnston George W.
Kestler Kimberly J.
LandOfFree
Vitamin D3 analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitamin D3 analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitamin D3 analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-30076